Author:
Karakurt Emin,Nuhoğlu Hilmi,Beytut Enver,Dağ Serpil
Reference31 articles.
1. Reference 1-Cristo TG, Vargas CB, Biezus G, Costa LS, Dal Pont TP, Kanamura CT, Salbego FZ, Traverso SD, Casagrande RA (2017). Braz J Vet Pathol, 10 (3), 105-110.
2. Reference 2-Fan TM, Barger AM, Sprandel IT, Fredrickson RL (2008). Investigating TrkA expression in canine appendicular osteosarcoma. J Vet Intern Med, 22 (5), 1181-1188.
3. Reference 3-Farese JP, Ashton J, Milner R, Ambrose LL, Van Gilder J (2004). The effect of the bisphosphonate alendronate on viability of canine osteosarcoma cells in vitro. In Vitro Cell Dev Biol Anim, 40 (3-4), 113-117.
4. Reference 4-Fieten H, Spee B, Ijzer J, Kik MJ, Penning LC, Kirpensteijn J (2009). Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma. Vet Pathol, 46 (5), 869-877.
5. Reference 5-Gebhard C, Fuchs-Baumgartinger A, Razzazi-Fazeli E, Miller I, Walter I (2016). Distribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma. Can J Vet Res, 80 (1), 66-73.